13 insiders reported 85 Form 4 transactions for Theravance Biopharma, Inc. (TBPH) over the past 18 months (most recent 2026-07-01). Recent activity: Samaha Eli (Insider) Sell 273,871 shares, Samaha Eli (Insider) Sell 25,027 shares, Samaha Eli (Insider) Sell 37,799 shares, Miller Aine (SVP, DEV & HEAD OF IRE OFFICE) Buy 18,750 shares, Farnum Rhonda (SVP, COMM & MEDICAL AFFAIRS) Sell 3,329 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Samaha Eli | Insider | Sell | 273,871 | $4.7M |
| 2026-07-01 | Samaha Eli | Insider | Sell | 25,027 | $428,788 |
| 2026-07-01 | Samaha Eli | Insider | Sell | 37,799 | $642,628 |
| 2026-06-23 | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | Buy | 18,750 | $0 |
| 2026-06-17 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 3,329 | $54,563 |
| 2026-06-17 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 3,328 | $54,525 |
| 2026-06-17 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 6,657 | $109,079 |
| 2026-06-16 | MITCHELL DEAN J | Director | Buy | 6,009 | $0 |
| 2026-06-16 | PAKIANATHAN DEEPIKA | Director | Buy | 6,009 | $0 |
| 2026-06-16 | Smaldone Alsup Laurie | Director | Buy | 6,009 | $0 |
| 2026-06-16 | O'Connor Donal | Director | Buy | 6,009 | $0 |
| 2026-06-16 | GRAY SUSANNAH | Director | Buy | 6,009 | $0 |
| 2026-05-22 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 5,678 | $93,971 |
| 2026-05-22 | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Sell | 8,670 | $143,488 |
| 2026-05-22 | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Sell | 8,829 | $146,120 |
| 2026-05-22 | Miller Aine | SVP, DEV & HEAD OF IRE OFFICE | Sell | 6,827 | $112,987 |
| 2026-05-22 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Sell | 20,038 | $331,629 |
| 2026-04-03 | Winningham Rick E | CHIEF EXECUTIVE OFFICER | Buy | 75,000 | $0 |
| 2026-04-03 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Buy | 18,750 | $0 |
| 2026-04-03 | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | Buy | 37,500 | $0 |
| 2026-04-03 | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Buy | 37,500 | $0 |
| 2026-03-18 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 7,767 | $108,117 |
| 2026-03-18 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 15,534 | $217,476 |
| 2026-03-18 | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Sell | 7,766 | $108,103 |
| 2026-02-24 | Sawaf Aziz | SVP & CHIEF FINANCIAL OFFICER | Sell | 20,672 | $406,412 |
Source: SEC Form 4 filings · as of 2026-07-01